Our optimized assay addresses these limitations by enabling the simultaneous sorting and analysis of both HCV-specific CD4 and CD8 T cells from the same sample, irrespective of MHC background, thus providing a more comprehensive understanding of HCV-specific immune responses in a diverse population and upon infection with diverse viral variants. Here, CD8A is linked to infection.